Increasing dose of methylprednisolone pulse therapy treats desquamative interstitial pneumonia in a child

European Respiratory Journal

Volumn 14, Issue 6, 1999, Pages 1429-1432

  Paul, K ^a,b   Klettke, U ^a   Moldenhauer, J ^a   Muller K M ^c   Kleinau, I ^a   Magdorf, K ^a   Wahn, U ^a  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c NONE

Author keywords

Desquamative interstitial pneumonia; Dose adjustments; Pulse therapy

Indexed keywords

ERYTHROMYCIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MUCOLYTIC AGENT;

ANTHROPOMETRY; ARTICLE; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; DOSE CALCULATION; ESCHERICHIA COLI; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0033375264     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14614299     Document Type: Article

References (24)

1. Laraya-Cuasay LR. Desquamative interstitial pneumonitis. In: Laraya-Cuasay LR, Hughes WT. Interstitial Lung Diseases in Children Volume 3. Boca Raton, FL, USA, CRC Press, 1988; pp. 130-133.
2. Bonanni PP, Frymoyer JW, Jacox RF. A family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease. Am J Med 1965; 39: 411-421.
3. Sharief N, Crawford OF, Dinwiddie R. Fibrosing alveolitis and desquamative interstitial pneumonia. Pediatr Pulmonol 1994; 17: 359-365.
4. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald M, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-809.
5. Farrell PM, Gilbert EF, Zimmermann JJ, Warner TF, Saari TN. Familial lung disease associated with proliferation and desquamation of type II pneumonocytes. Am J Dis Child 1986; 140: 262-266.
6. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39: 369-404.
7. Scully RE, Mark EJ, McNeely BU. Case 9-1983 - Case records of the Massachusetts General Hospital. N Engl J Med 1983; 308: 511-519.
8. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case 49-1993 - Case records of the Massachusetts General Hospital. N Engl J Med 1993; 329: 1797-1805.
9. Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative intersitial pneumonia in three infants siblings. J Pediatr 1984; 104: 873-876.
10. Brugman S, Wilson H, Fan L. Interstitial lung disease. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore, MD, USA, Williams & Wilkins, 1994; pp. 395-410.
11. Feigin DS, Friedmann PJ. Chest radiography in desquamative interstitial pneumonitis: a review of 37 patients. Am J Roentgenol 1980; 134: 91-99.
12. Seymor JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte macrophage colony stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996; 335: 1924-1925.
13. Bhagwat AG, Wentworth P, Conen PE. Observations on the relationship of desquamative interstitial pneumonia and pulmonary alveolar proteinosis in childhood. A pathologic and experimental study. Chest 1970; 58: 326-332.
14. Balasubramanyan N, Murphy A, O'Sullivan J, O'Connell EJ. Familial interstitial lung disease in children: response to chloroquine treatment in one sibling with desquamative interstitial pneumonitis. Pediatr Pulmonol 1997; 23: 55-61.
15. Hartmann TE, Primack SL, Kang KY, et al. Disease progression in usual interstitial pneumonia compared with desquamative intersititial pneumonia. Assessment with serial CT. Chest 1996; 110: 378-382.
16. Avital A, Godfrey S, Maayan C, Diamant Y, Springer C. Chloroquine treatment of interstitial lung disease in children. Pediatr Pulmonol 1994; 18: 356-360.
17. Kerem E, Bentur L, England S, et al. Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis. J Pediatr 1990; 116: 61-67.
18. Osika E, Muller MH, Boccon-Gibod L, et al. Idiopathic pulmonary fibrosis in infants. Pediatr Pulmonol 1997; 23: 49-54.
19. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmakoi Science 1993; 14: 436-441.
20. Boumpas DT, Chrousors CP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases. Basic and clinical correlates. Ann Intern Med 1993; 119: 1198-1205.
21. Desmarquest P, Tamalet A, Fauroux B, et al. Chronic interstitial lung disease in children: response to high-dose intravenous methylprednisolone pulses. Pediatr Pulmonol 1998; 26: 332-338.
22. Kleinau I, Perez-Canto A, Schmid HJ, et al. Case report. Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1997; 19: 841-844.
23. Bernini JC, Carrillo JM, Buchanan GR. High-dose intravenous methylprednisolone therapy for patients with Diamond-Blachfan anemia refractory to conventional doses of prednisone. J Pediatr 1995; 127: 654-659.
24. Easterbrook M. Ocular effects and safety of antimalarial agents. Am J Med 1988; 85: 23-29.